Additionally, CRABP2 was found to be highly expressed in ovarian cancer tissues compared to normal tissues, and its expression level correlated positively with tumor malignancy, including histopathological grade, clinical stage, and metastasis. Here, CRABP2 is linked to ovarian cancer.